Intracellular signal transduction in eosinophils and its clinical significance

Immunopharmacology and Immunotoxicology

Volumn 24, Issue 2, 2002, Pages 165-186

  Wong, Chun Kwok ^a   Zhang, Jiping ^b   Ip, Wai Ki ^a   Lam, Christopher Wai Kei ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Eosinophils; Eotaxin; GM CSF; IL 3; IL 5; JAK; MAPK; NF B; PI3K; STAT

Indexed keywords

CHEMOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; INTERLEUKIN 5; JANUS KINASE; MAJOR BASIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT PROTEIN; CYTOKINE RECEPTOR; EOSINOPHIL CHEMOTACTIC FACTOR;

ALLERGIC DISEASE; ALLERGIC RHINITIS; APOPTOSIS; ASTHMA; CELL FUNCTION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EFFECTOR CELL; EOSINOPHIL; EOSINOPHILIA; HUMAN; INCIDENCE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE INJURY; ANIMAL; BIOLOGICAL MODEL; HYPERSENSITIVITY; IMMUNOLOGY; INTRACELLULAR FLUID; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMAL; CHEMOTACTIC FACTORS, EOSINOPHIL; EOSINOPHILS; HUMAN; HYPERSENSITIVITY; INTRACELLULAR FLUID; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, IMMUNOLOGICAL; NF-KAPPA B; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS;

JANUS;

EID: 0035989709     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120003748     Document Type: Review

References (129)

1. Eosinophils: Structure and functions
2. Advances in the immunobiology of eosinophils and their role in disease
3. Mechanisms of eosinophil-associated inflammation
4. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils
5. Interleukin-18 enhances the production of interleukin-8 by eosinophils
6. Stimulation of degranulation from human eosinophils by platelet-activating factor
7. Priming of the respiratory burst in human eosinophils is accompanied by changes in signal transduction
8. Chemotactic agonists induce cytokine generation in eosinophils
9. The molecular biology of leukocyte chemoattractant receptors
10. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit
11. Signal transduction in eosinophils
12. Heterotrimeric G proteins: Organizers of transmembrane signals
13. Chemoattractant signaling and leukocyte activation
14. PAF receptors G-proteins in human blood eosinophils neutrophils
15. Controlling allergic inflammation by signaling regulation of eosinophils
16. Eotaxin and eosinophil recruitment: Implications for human disease
17. Intracellular localization and release of eotaxin from normal eosinophils
18. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
19. Chemokines induce eosinophil degranulation through CCR-3
20. Asthma, eosinophils and neutrophils
21. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
22. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration
23. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases
24. CCR3 blockade as a new therapy for asthma
25. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
26. A critical cytoplasmic domain of the interleukin 5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction
27. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils
28. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils
29. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and STAT1α
30. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
31. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C(4) biosynthesis
32. Pro-inflammatory cytokines and environmental stress cause p38 mitogen- activated protein kinase activation by dual phosphorylation on tyrosine and threonine
33. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
34. p38 MAPK signalling cascades in inflammatory disease
35. The mitogen-activated protein kinase signal transduction pathway
36. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils
37. The mechanism of IL-5 signal transduction
38. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils
39. Differentiation of a human eosinophilic leukemic cell line, EoL-1: Characterization by the expression of cytokine receptors, adhesion molecules, CD95 and eosinophilic cationic protein (ECP)
40. Sodium salicylate-induced apoptosis of human peripheral blood eosinophils is independent of the activation of C-Jun N-terminal kinase and p38 mitogen-activated protein kinase
41. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death
42. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
43. SB 203580, An inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils
44. Tumor necrosis factor-alpha mediate antiapoptotic signals partially via p38 MAP kinase activation in human eosinophils
45. Role of caspase in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils
46. Requirement of Lyn and Syk tyrosine kinase for the prevention of apoptosis by cytokines in human eosinophils
47. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation
48. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils
49. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEK-micro-tubule-associated protein kinase pathway
50. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain
51. Association between Lyn protein tyrosine kinase (p53/56lyn) and the beta subunit of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human megakaryocytic leukemia cell line (M-07e)
52. Tec protein-tyrosine kinase is involved in interleukin-3 signaling pathway
53. Binding of Src-like kinases to the beta-subunit of the interleukin-3 receptor
54. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor
55. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils
56. STATs and gene regulation
57. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
58. Roles of JAK kinases in human GM-CSF receptor signal transduction
59. Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines
60. Identification of a viability domain in the granulocyte/macrophage colony-stimulating factor receptor beta-chain involving tyrosine-750
61. Multiple tyrosine residues in the intracellular domain of the common beta subunit of the interleukin 5 receptor are involved in activation of STAT5
62. Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival
63. Physical and functional interactions between Stat5 and the tyrosinephosphorylated receptors for erythropoietin and interleukin-3
64. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands
65. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3
66. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands
67. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins
68. Involvement of JAK2, but not PI 3-kinase/Akt and MAP kinase pathways, in anti-apoptotic signals of GM-CSF in human eosinophils
69. Signalling through the lipid products of phosphoinositide-3-OH kinase
70. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5
71. Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils
72. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase
73. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils
74. Phosphoinositide 3-kinase: A key biochemical signal for cell migration in response to chemokines
75. The role of nuclear factor-κB in cytokine gene regulation
76. The p65 subunit is responsible for the strong transcription activating potential of NF-κB
77. Nuclear factor kappa B mediates interleukin-8 production in eosinophils
78. The Rel/NF-kappaB signal transduction pathway: Introduction
79. The NF-kappa B and I kappa B proteins: New discoveries and insights
80. Nuclear factor kappa B mediates interleukin-8 production in eosinophils
81. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132
82. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation
83. Activation and localization of transcription factor, nuclear factor-κB, in asthma
84. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells
85. Bcl-2 downregulates the activity of transcription factor NF-kappaB induced upon apoptosis
86. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
87. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2
88. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro
89. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody
90. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3
91. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C
92. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamy-lamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells
93. Synthesis and characterization of calmodulin antagonistic drugs
94. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
95. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
96. Pharmacological profile of SB 203580, A selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
97. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence
98. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
99. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils
100. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
101. Transcription factors and asthma
102. Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells
103. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132
104. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
105. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines
106. The CC chemokine receptor 3 CCR3 is functionally expressed on eosinophils but not on neutrophils
107. The CC chemokine receptor antagonist Net-RANTES inhibits eosinophil effector functions
108. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains
109. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
110. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys
111. The role of adhesion molecules in human eosinophil and basophil recruitment
112. Blockade of JAK2 by tyrphostin AG-490 inhibits antigen-induced eosinophil recruitment into the mouse airways
113. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma
114. Effect of anti-ICAM-1 on bronchial response: Bronchoalveolar Lavage Fluid (BALF) and ultrastructural changes of bronchial epithelium in guinea pigs with dual phase bronchial response
115. Role of exhaled nitric oxide in asthma
116. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice
117. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily
118. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils
119. Analysis of cellular adhesion by microarray expression profiling
120. Expression profile of active genes in granulocytes
121. Eosinophilia
122. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
123. Eosinophil as a therapeutic target in allergic disease
124. Pharmacological manipulation of granulocyte apoptosis: Potential therapeutic targets
125. Nitric oxide inhibits c-Jun N-terminal kinase 2 (JNK2) via S-nitrosylation
126. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways
127. Regulation of granulocyte apoptosis by PKC inhibition and elevation of [Ca2+]i
128. Apoptosis of eosinophils and lymphocytes in allergic inflammation
129. Pharmacological manipulation of granulocyte apoptosis: Potential therapeutic targets